Compugen Ltd (CGEN)

Israel: Silberman appointed as new CFO at Compugen - Investors in Healthcare

Investors in Healthcare

Compugen names David Silberman as new CFO By Investing.com - Investing.com

Investing.com

Compugen Appoints David Silberman as Chief Financial Officer - PR Newswire

PR Newswire

Compugen (CGEN) Scheduled to Post Quarterly Earnings on Monday - MarketBeat

MarketBeat

Compugen (CGEN) to Release Earnings on Monday - Defense World

Defense World

Compugen (NASDAQ:CGEN) Shares Pass Above Two Hundred Day Moving Average of $1.78 - MarketBeat

MarketBeat

Compugen (NASDAQ:CGEN) Share Price Crosses Above 200-Day Moving Average of $1.78 - Defense World

Defense World

Compugen (NASDAQ:CGEN investor three-year losses grow to 90% as the stock sheds US$11m this past week - Yahoo New Zealand News

Yahoo New Zealand News

Compugen (NASDAQ:CGEN) Stock Price Passes Above 200 Day Moving Average of $1.73 - MarketBeat

MarketBeat

INVA: 3 Biotech Stocks with Potential Gains - Watch or Buy? - StockNews.com

StockNews.com

Are You Looking for a Top Momentum Pick? Why Compugen (CGEN) is a Great Choice

Zacks Investment Research

Compugen Ltd. (NASDAQ:CGEN) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Compugen Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Yahoo Finance

Compugen: Q4 Earnings Snapshot - Quartz

Quartz

BOX Gears Up to Report Q4 Earnings: Here's What to Expect

Zacks Investment Research

Will Petrobras (PBR) Report Q4 Earnings Beat on Output Gains?

Zacks Investment Research

Is a Surprise Coming for Compugen (CGEN) This Earnings Season?

Zacks Investment Research

Is a Surprise Coming for Compugen (CGEN) This Earnings Season? - Yahoo Finance

Yahoo Finance

Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?

Zacks Investment Research

Baidu (BIDU) to Report Q4 Earnings: What's in the Offing?

Zacks Investment Research

Vipshop (VIPS) to Post Q4 Earnings: What's in the Offing?

Zacks Investment Research

ACM Research (ACMR) to Report Q4 Earnings: What's in Store?

Zacks Investment Research

What to Look for in Crescent Point's (CPG) Q4 Earnings?

Zacks Investment Research

Compugen (CGEN) Scheduled to Post Quarterly Earnings on Tuesday - American Banking and Market News

American Banking and Market News

Agilent Technologies (A) to Post Q1 Earnings: What's in Store?

Zacks Investment Research

What's in Store for Qurate Retail (QRTEA) in Q4 Earnings?

Zacks Investment Research

Ginkgo (DNA) to Report Q4 Earnings: What's in the Cards?

Zacks Investment Research

Eton Pharma (ETON) to Report Q4 Earnings: What's in the Cards?

Zacks Investment Research

Compugen (CGEN) is a Great Momentum Stock: Should You Buy?

Zacks Investment Research

Compugen (NASDAQ:CGEN) Is In A Good Position To Deliver On Growth Plans - Simply Wall St

Simply Wall St

Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer - PR Newswire

PR Newswire

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 ... - Yahoo Finance

Yahoo Finance

Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More

Zacks Investment Research

Gilead (GILD), Compugen Collaborate for Immunotherapy Program

Zacks Investment Research

Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last ... - Yahoo Finance

Yahoo Finance

Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge

Benzinga

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results

Benzinga

Compugen's stock rockets on deal with Gilead for anti-tumor drug

MarketWatch

US Stocks Higher; Accenture Issues Weak Sales Outlook

Benzinga

Compugen signs cancer drug licensing deal with Gilead Sciences - Globes

Globes

Is Compugen (CGEN) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

Israel tops up budget for struggling biotechs amid continuing war challenges - BioWorld Online

BioWorld Online

EPO upholds Compugen patent for immunotherapy cancer treatment - JUVE Patent

JUVE Patent

Targeting IL-18BP with COM-503 is an immunotherapeutic approach for cancer - BioWorld Online

BioWorld Online

12 Best One Dollar Stocks to Buy According To Hedge Funds - Yahoo Finance

Yahoo Finance

AstraZeneca Launches Phase II Trial of Anti-TIGIT NSCLC Therapy (Updated) - BioSpace

BioSpace

Compugen changes drug discovery business strategy - Globes - Globes

Globes

Cathie Wood Could Be Right on Down-and-Out Compugen After-All - TheStreet

TheStreet

Did Compugen's (NASDAQ:CGEN) Share Price Deserve to Gain 94%? - Yahoo News UK

Yahoo News UK